Previous trials investigating matched tumor biopsies before and after neoadjuvant chemotherapy and/or radiotherapy showed varying levels of change in PD-L1 expression.7–12 However, these studies were limited by the long intervals between neoadjuvant treatment and tissues obtained at surgery, as well as the heterogeneity of tumor sampling. The gene discussed is CD274; the disease is neoplasm.